Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAROTRECTINIB vs LATISSE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAROTRECTINIB vs LATISSE: Safety Overview

Metric LAROTRECTINIB LATISSE
Total FAERS Reports 798 980
Deaths Reported 149 0
Death Rate 18.7% N/A
Hospitalizations 151 0
Average Patient Age 48.9 yrs 53.0 yrs
% Female Patients 51.5% N/A
FDA Approval Date Nov 26, 2018 N/A
Manufacturer Bayer HealthCare Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A